SwePub
Sök i LIBRIS databas

  Utökad sökning

(WFRF:(Sabri Osama))
 

Sökning: (WFRF:(Sabri Osama)) > (2021) > Clinical validity o...

  • Bischof, Gérard N.University Hospital of Cologne (författare)

Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

  • Artikel/kapitelEngelska2021

Förlag, utgivningsår, omfång ...

  • 2021-02-16
  • Springer Science and Business Media LLC,2021
  • 11 s.

Nummerbeteckningar

  • LIBRIS-ID:oai:lup.lub.lu.se:0807754e-355c-4778-8398-b1d7710767cf
  • https://lup.lub.lu.se/record/0807754e-355c-4778-8398-b1d7710767cfURI
  • https://doi.org/10.1007/s00259-020-05156-4DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:145907514URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:for swepub-publicationtype
  • Ämneskategori:ref swepub-contenttype

Anmärkningar

  • Purpose: In 2017, the Geneva Alzheimer’s disease (AD) strategic biomarker roadmap initiative proposed a framework of the systematic validation AD biomarkers to harmonize and accelerate their development and implementation in clinical practice. Here, we use this framework to examine the translatability of the second-generation tau PET tracers into the clinical context. Methods: All available literature was systematically searched based on a set of search terms that related independently to analytic validity (phases 1–2), clinical validity (phase 3–4), and clinical utility (phase 5). The progress on each of the phases was determined based on scientific criteria applied for each phase and coded as fully, partially, preliminary achieved or not achieved at all. Results: The validation of the second-generation tau PET tracers has successfully passed the analytical phase 1 of the strategic biomarker roadmap. Assay definition studies showed evidence on the superiority over first-generation tau PET tracers in terms of off-target binding. Studies have partially achieved the primary aim of the analytical validity stage (phase 2), and preliminary evidence has been provided for the assessment of covariates on PET signal retention. Studies investigating of the clinical validity in phases 3, 4, and 5 are still underway. Conclusion: The current literature provides overall preliminary evidence on the establishment of the second-generation tau PET tracers into the clinical context, thereby successfully addressing some methodological issues from the tau PET tracer of the first generation. Nevertheless, bigger cohort studies, longitudinal follow-up, and examination of diverse disease population are still needed to gauge their clinical validity.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Dodich, AlessandraUniversity of Trento,University of Geneva (författare)
  • Boccardi, MarinaGerman Center for Neurodegenerative Diseases (DZNE), Bonn (författare)
  • van Eimeren, ThiloGerman Center for Neurodegenerative Diseases (DZNE), Bonn,University Hospital of Cologne (författare)
  • Festari, CristinaCentro San Giovanni di Dio Fatebenefratelli (författare)
  • Barthel, HenrykLeipzig University (författare)
  • Hansson, OskarLund University,Lunds universitet,Klinisk minnesforskning,Forskargrupper vid Lunds universitet,Clinical Memory Research,Lund University Research Groups,Skåne University Hospital(Swepub:lu)mphy-ohn (författare)
  • Nordberg, AgnetaKarolinska Institutet,Karolinska Institute (författare)
  • Ossenkoppele, RikLund University,Lunds universitet,Klinisk minnesforskning,Forskargrupper vid Lunds universitet,Clinical Memory Research,Lund University Research Groups,Vrije Universiteit Amsterdam(Swepub:lu)ri1513os (författare)
  • Sabri, OsamaLeipzig University (författare)
  • Giovanni, B. Frisoni G.University of Geneva,Geneva University Hospital (författare)
  • Garibotto, ValentinaUniversity of Geneva,Geneva University Hospital (författare)
  • Drzezga, AlexanderUniversity Hospital of Cologne,German Center for Neurodegenerative Diseases (DZNE), Bonn (författare)
  • University Hospital of CologneUniversity of Trento (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:European Journal of Nuclear Medicine and Molecular Imaging: Springer Science and Business Media LLC48:7, s. 2110-21201619-70701619-7089

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy